» Authors » Sandra Ferreyra Vega

Sandra Ferreyra Vega

Explore the profile of Sandra Ferreyra Vega including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 176
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kling T, Ferreyra Vega S, Suman M, Denes A, Lipatnikova A, Lagerstrom S, et al.
Brain Pathol . 2024 Jan; 34(5):e13233. PMID: 38168467
The 2021 World Health Organization (WHO) grading system of isocitrate dehydrogenase (IDH)-mutant astrocytomas relies on histological features and the presence of homozygous deletion of the cyclin-dependent kinase inhibitor 2A and...
2.
Denes A, Bontell T, Barcheus H, Ferreyra Vega S, Caren H, Lindskog C, et al.
PLoS One . 2023 May; 18(5):e0285732. PMID: 37192181
Objectives: Accumulating evidence shows that mesenchymal transition of glioblastomas is associated with a more aggressive course of disease and therapy resistance. In WHO2021-defined adult-type diffuse gliomas of lower grade (dLGG),...
3.
Wei Y, Li G, Feng J, Wu F, Zhao Z, Bao Z, et al.
Genome Med . 2023 Apr; 15(1):24. PMID: 37055795
Background: Roughly 50% of adult gliomas harbor isocitrate dehydrogenase (IDH) mutations. According to the 2021 WHO classification guideline, these gliomas are diagnosed as astrocytomas, harboring no 1p19q co-deletion, or oligodendrogliomas,...
4.
Ferreyra Vega S, Bontell T, Kling T, Jakola A, Caren H
Acta Neuropathol Commun . 2023 Feb; 11(1):23. PMID: 36739454
Diffuse gliomas are the most prevalent malignant primary brain tumors in adults and remain incurable despite standard therapy. Tumor recurrence is currently inevitable, which contributes to a persistent high morbidity...
5.
Schepke E, Lofgren M, Pietsch T, Bontell T, Kling T, Wenger A, et al.
Neuropathol Appl Neurobiol . 2022 Jul; 48(6):e12838. PMID: 35892159
Aims: Paediatric brain tumours are rare, and establishing a precise diagnosis can be challenging. Analysis of DNA methylation profiles has been shown to be a reliable method to classify central...
6.
Wenger A, Ferreyra Vega S, Schepke E, Lofgren M, Bontell T, Tisell M, et al.
Acta Neuropathol Commun . 2022 Jul; 10(1):105. PMID: 35842717
DNA methylation is increasingly used for tumour classification and has expanded upon the > 100 currently known brain tumour entities. A correct diagnosis is the basis for suitable treatment for...
7.
Corell A, Vecchio T, Ferreyra Vega S, Denes A, Neimantaite A, Hagerius A, et al.
Neurooncol Adv . 2022 Jul; 4(1):vdac074. PMID: 35795469
Background: The subventricular zone (SVZ) of the human brain is a site of adult stem cell proliferation and a microenvironment for neural stem cells (NSCs). It has been suggested that...
8.
Ferreyra Vega S, Wenger A, Kling T, Bontell T, Jakola A, Caren H
Mod Pathol . 2022 Jun; 35(11):1551-1561. PMID: 35701666
Adult-type diffuse gliomas and meningiomas are the most common primary intracranial tumors of the central nervous system. DNA methylation profiling is a novel diagnostic technique increasingly used also in the...
9.
Carstam L, Corell A, Smits A, Denes A, Barcheus H, Modin K, et al.
Front Oncol . 2022 Jan; 11:803975. PMID: 35083156
Background: While molecular insights to diffuse lower-grade glioma (dLGG) have improved the basis for prognostication, most established clinical prognostic factors come from the pre-molecular era. For instance, WHO grade as...
10.
Ferreyra Vega S, Bontell T, Corell A, Smits A, Jakola A, Caren H
Clin Epigenetics . 2021 May; 13(1):102. PMID: 33941250
Background: DNA methylation profiling has facilitated and improved the classification of a wide variety of tumors of the central nervous system. In this study, we investigated the potential utility of...